Global Protein Crystallization Market Report and Forecast 2024-2032

Global Protein Crystallization Market Report and Forecast 2024-2032


Global Protein Crystallization Market Outlook

The global protein crystallization market was valued USD 1.5 billion in 2023, driven by the research capabilities, pharmaceutical industry strength, and government support has led to market growth across the globe. The market size is anticipated to grow at a CAGR of 8.0% during the forecast period of 2024-2032 to achieve a value of USD 2.8 billion by 2032.

Protein Crystallization: Introduction

Protein crystallization is a crucial process in the field of structural biology and drug development. It involves the formation of highly ordered three-dimensional arrangements of protein molecules in the form of crystals. These protein crystals can be analysed using techniques like X-ray crystallography and cryo-electron microscopy to determine the protein's atomic structure. Understanding a protein's structure is fundamental to deciphering its function and designing targeted therapies, making protein crystallization an essential step in drug discovery and the study of various diseases. The process of protein crystallization requires careful optimization of conditions like pH, temperature, and precipitants to encourage crystal growth. It plays a pivotal role in advancing our knowledge of biology and facilitating the development of new drugs and treatments.

Key Trends in the Global Protein Crystallization Market
  • Microfluidics: Microfluidic devices are gaining traction for protein crystallization. These devices enable precise control over fluid handling and offer a platform for efficient and reproducible crystal growth.
  • Cryo-EM and Serial Crystallography: Cryo-electron microscopy (cryo-EM) and serial crystallography are emerging techniques that complement traditional X-ray crystallography. They allow researchers to study protein structures without the need for large, high-quality crystals, expanding the scope of structural biology.
  • Artificial Intelligence (AI) and Machine Learning: AI and machine learning are being employed to predict optimal crystallization conditions based on protein characteristics and previous data. These technologies accelerate the crystallization process and improve success rates.
  • Miniaturization and Microgravity Experiments: Miniaturized crystallization experiments and experiments conducted in microgravity environments (e.g., on the International Space Station) offer unique conditions for growing high-quality protein crystals, contributing to structural biology research.
Global Protein Crystallization Market Segmentation

The market can be categorised into product, technology, end user and region.

Market Breakup by product
  • Instruments
  • Consumables
  • Software & Services
Market Breakup by technology
  • X-ray Crystallography
  • Cryo-electron Microscopy
  • NMR Spectroscopy
  • Others
Market Breakup by End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Government Institutes
  • Academic Institutions
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Protein Crystallization Market Overview

The global protein crystallization market is a vital segment of the biotechnology and pharmaceutical industries, serving as a critical component of structural biology research and drug development. The protein crystallization market has been experiencing steady growth due to increasing demand for structural insights into biological molecules and the development of novel drugs. Protein crystallization is essential for determining the three-dimensional structures of proteins, enabling a deeper understanding of their functions and interactions.

North America, encompassing the United States and Canada, plays a prominent role in the global protein crystallization market, benefiting from a well-established pharmaceutical sector, extensive academic research, and substantial investments in drug development. Leading pharmaceutical firms and research institutions actively drive market growth, with advanced technology and a skilled workforce fostering the adoption of protein crystallization techniques. In Western Europe, including countries like Germany, France, the United Kingdom, and Switzerland, a robust presence is observed due to advanced pharmaceutical sectors, renowned research institutions, and a history of innovation in structural biology, supported by government funding and academia-industry collaborations. Eastern Europe also participates in market expansion with increased investments in research infrastructure and a growing focus on structural biology.

Key Players in the Global Protein Crystallization Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in global protein crystallization market are as follows:
  • Bruker
  • HAMPTON RESEARCH CORP.
  • Rigaku Corporation
  • Mettler Toledo
  • Corning Incorporated
  • Jena Bioscience Gmbh
  • Creative Proteomics
  • Formulatrix
  • Molecular Dimensions
  • Greiner Bio-One International Gmbh
  • SARomics Biostructures AB
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Protein Crystallization Market Overview
3.1 Global Protein Crystallization Market Historical Value (2017-2023)
3.2 Global Protein Crystallization Market Forecast Value (2024-2032)
4 Global Protein Crystallization Market Landscape
4.1 Global Protein Crystallization Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Protein Crystallization Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Technology
5 Global Protein Crystallization Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Protein Crystallization Market Segmentation
6.1 Global Protein Crystallization Market by Product
6.1.1 Market Overview
6.1.2 Instruments
6.1.3 Consumables
6.1.4 Software and Services
6.2 Global Protein Crystallization Market by Technology
6.2.1 Market Overview
6.2.2 X-ray Crystallography
6.2.3 Cryo-electron Microscopy
6.2.4 NMR Spectroscopy
6.2.5 Others
6.3 Global Protein Crystallization Market by End User
6.3.1 Market Overview
6.3.2 Pharmaceutical Companies
6.3.3 Biotechnology Companies
6.3.4 Government Institutes
6.3.5 Academic Institutions
6.3.6 Others
6.4 Global Protein Crystallization Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Protein Crystallization Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Protein Crystallization Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Protein Crystallization Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Protein Crystallization Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Protein Crystallization Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Bruker
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 HAMPTON RESEARCH CORP.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Rigaku Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Mettler Toledo
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Corning Incorporated
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Jena Bioscience Gmbh
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Creative Proteomics
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Formulatrix
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Molecular Dimensions
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Greiner Bio-One International Gmbh
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 SARomics Biostructures AB
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Protein Crystallization Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings